299. 嚢胞性線維症 Cystic fibrosis Clinical trials / Disease details
臨床試験数 : 1,696 / 薬物数 : 1,644 - (DrugBank : 272) / 標的遺伝子数 : 96 - 標的パスウェイ数 : 170
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00179998 (ClinicalTrials.gov) | January 2005 | 10/9/2005 | Effectiveness of Pulmozyme in Infants With Cystic Fibrosis | Efficacy of Pulmozyme in Infants and Young Children With Cystic Fibrosis | Cystic Fibrosis | Drug: Recombinant Human DNase (Pulmozyme);Drug: Placebos | Nationwide Children's Hospital | Genentech, Inc. | Completed | 1 Month | 30 Months | All | 24 | Phase 2 | United States |